Paclitaxel plus carboplatin, compared with paclitaxel plus gemcitabine, shows similar efficacy while more cost-effective: a randomized phase II study of combination chemotherapy against inoperable non-small-cell lung cancer previously untreated
| Autor: | Chen, Y.-M. *, Perng, R.-P., Lee, Y.-C., Shih, J.-F., Lee, C.-S., Tsai, C.-M., Whang-Peng, J. |
|---|---|
| Zdroj: | In Annals of Oncology January 2002 13(1):108-115 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|